Stockscreener 앱 받기
3.67
5.66%
-0.22
시간 외 거래:
3.67
전일 마감가:
$3.89
열려 있는:
$3.8
하루 거래량:
7.06M
Relative Volume:
1.58
시가총액:
$1.30B
수익:
$9.68M
순이익/손실:
$-250.64M
주가수익비율:
-2.6218
EPS:
-1.3998
순현금흐름:
$-89.83M
1주 성능:
+11.89%
1개월 성능:
-3.17%
6개월 성능:
+4.56%
1년 성능:
+123.78%
1일 변동 폭
$3.62
$4.00
1주일 범위
$3.04
$4.275
52주 변동 폭
$1.11
$5.465
Precigen Inc Stock (PGEN) Company Profile
명칭
Precigen Inc
전화
301-556-9900
주소
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Compare PGEN vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PGEN
Precigen Inc
|
3.67 | 1.38B | 9.68M | -250.64M | -89.83M | -1.3998 |
VRTX
Vertex Pharmaceuticals Inc
|
433.07 | 115.27B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
737.71 | 80.00B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
691.40 | 43.00B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
317.36 | 43.52B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
283.03 | 30.74B | 5.36B | 287.73M | 924.18M | 2.5229 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-15 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-03-22 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-05-23 | 개시 | JP Morgan | Neutral |
| 2022-11-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-02-25 | 개시 | Stifel | Buy |
| 2021-02-22 | 개시 | Wells Fargo | Overweight |
| 2021-02-18 | 개시 | B. Riley Securities | Buy |
| 2020-05-08 | 개시 | H.C. Wainwright | Buy |
모두보기
Precigen Inc 주식(PGEN)의 최신 뉴스
HC Wainwright Has Positive Estimate for Precigen Q3 Earnings - MarketBeat
Discover Precigen And 2 Other Insider-Favored Growth Stocks - Yahoo Finance
Is It Too Late To Consider Precigen (PGEN) After Its 145% One Year Surge? - Yahoo Finance
Precigen Earnings Call Signals Powerful Launch Momentum - TipRanks
Analyst Upgrade: Whats the beta of Precigen Inc stockMarket Weekly Review & Fast Gain Stock Tips - baoquankhu1.vn
Precigen: The Best Potential Blockbuster You've Never Heard Of (Your ENT Has) - Seeking Alpha
These Analysts Boost Their Forecasts On Precigen Following Q4 Results - Benzinga
Precigen (PGEN) Soars 26% Despite Missed Revenue Estimates - GuruFocus
Precigen (NASDAQ:PGEN) Shares Gap Up Following Analyst Upgrade - MarketBeat
Precigen (PGEN) Shares Surge on Positive Q1 Outlook Despite Earnings Miss - GuruFocus
Olaplex, Kodiak Sciences, Precigen And Other Big Stocks Moving Higher On Thursday - Benzinga
Precigen (NASDAQ:PGEN) Price Target Raised to $9.00 at Citizens Jmp - MarketBeat
PGEN: Analyst Jason N. Butler Raises Price Target to $9 | PGEN S - GuruFocus
Precigen stock gains on Q1 2026 outlook (PGEN:NASDAQ) - Seeking Alpha
PGEN: HC Wainwright & Co. Raises Price Target to $10.00 | PGEN S - GuruFocus
H.C. Wainwright raises Precigen stock price target on sales growth By Investing.com - Investing.com India
Precigen (NASDAQ:PGEN) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
Precigen, Inc. (NASDAQ:PGEN) Q4 2025 Earnings Call Transcript - Insider Monkey
H.C. Wainwright raises Precigen stock price target on sales growth - Investing.com
Precigen (PGEN) Reports Strong Q4 2025 with PAPZIMEOS Launch - GuruFocus
Citizens raises Precigen stock price target on strong PAPZIMEOS sales By Investing.com - Investing.com Australia
Citizens raises Precigen stock price target on strong PAPZIMEOS sales - Investing.com
Precigen Achieves First Commercial Revenue in 2025 with FDA Approval and Strong US Launch of PAPZIMEOS for RRP - Minichart
Precigen Inc. 2025 Annual Report: Papzimeos Launch, UltraCAR-T & AdenoVerse Platform, Clinical Pipeline, Risks, and Competitive Landscape 33 34 35 38 40 54 - Minichart
Beyond the Balance Sheet: What SWOT Reveals About Precigen Inc (PGEN) - GuruFocus
Precigen Inc (PGEN) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansion ... By GuruFocus - Investing.com Canada
Q3 2025 Precigen Inc Earnings Call Transcript - GuruFocus
Precigen Inc (PGEN) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansion Amidst Challenges - GuruFocus
Precigen Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Precigen, Inc. (PGEN) reports Q4 loss, lags revenue estimates - MSN
Precigen expects Q1 revenue to exceed $18M as PAPZIMEOS launch accelerates with broad US payer coverage - MSN
Precigen, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Precigen Q4 Earnings Call Highlights - Yahoo Finance
Precigen, Inc. (PGEN) Posts Fourth Quarter Loss, Misses Revenue Expectations - Bitget
PGEN: PAPZIMEOS launch accelerates revenue growth and adoption, with Q1 2026 revenue set to exceed $18M - TradingView
Earnings call transcript: Precigen Q4 2025 sees revenue surge, PAPZIMEOS gains traction By Investing.com - Investing.com South Africa
PGEN: Papzimeos launch accelerates revenue growth, with Q1 2026 sales expected to surpass $18 million - TradingView
Precigen (PGEN) Q4 2025 Earnings Call Transcript - The Globe and Mail
Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Earnings call transcript: Precigen Inc. beats revenue expectations in Q4 2025 - Investing.com
Earnings call transcript: Precigen Q4 2025 sees revenue surge, PAPZIMEOS gains traction - Investing.com UK
Precigen (NASDAQ:PGEN) Issues Earnings Results, Beats Expectations By $0.09 EPS - MarketBeat
Precigen Inc (NASDAQ:PGEN) Stock Surges on Narrower Loss and Commercial Transition After FDA Approval - ChartMill
Precigen 10-K: $9.68M Revenue, $(1.37) EPS on FY net loss - TradingView
Papzimeos launch marks new chapter for Precigen (NASDAQ: PGEN) as pipeline refocuses - Stock Titan
Precigen reports $9.7M revenue, $110.5M operating loss and $429.6M net loss to common in 2025 - TradingView
Q4 2025 Precigen Inc Earnings Call Transcript - GuruFocus
Precigen Reports Full Year 2025 Financial Results and Business Updates - PR Newswire
Precigen earnings up next: Can gene therapy launch offset losses? By Investing.com - Investing.com Australia
Precigen earnings up next: Can gene therapy launch offset losses? - Investing.com
Precigen Q4 2025 Earnings Call Transcript - MarketBeat
Precigen Inc (PGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.03%
2.20%
자본화:
|
볼륨(24시간):